Eden Spine Receives New Patent for Its Posterior Dynamic Stabilization System, the PERFX-2.pdf

About Global Documents

Global Documents provides you with documents from around the globe on a variety of topics for your enjoyment.

Global Documents utilizes edocr for all its document needs due to edocr's wonderful content features. Thousands of professionals and businesses around the globe publish marketing, sales, operations, customer service and financial documents making it easier for prospects and customers to find content.

Press Release Dynamic Stabilization System Eden Spine Guillaume Viallaneix CEO Patent Posterior Dynamic Stabilization Press Release distributed Release distributed term PERFX

Eden Spine Receives New Patent for Its Posterior Dynamic Stabilization System,
the PERFX-2
Lake Mary, FL,  September 08, 2010 --(PR.com)-- Eden Spine (www.EdenSpine.com), a Florida based
Medical Devices organization focused on developing the latest generation of spinal technologies, has
been granted a U.S. patent from the United States Patent and Trademark Office (USPTO) and from the
European Patent Office for the PERFX-2™, a Posterior Dynamic Stabilization system designed to
remove pain without necessarily removing motion.
The PERFX-2™ is a pedicle screw based dynamic stabilization system, CE Marked and currently
distributed internationally. According to Mourad Ben Mokhtar, head of Eden Spine's Research &
Development efforts, “The PERFX-2™ is the latest generation Dynamic Rod technology. It was designed
to achieve stabilization of the diseased spinal segment while closely replicating its natural function, for
better long term results.”
“Fusion has been the standard of care for debilitating back pain for over 3 decades,” said Guillaume
Viallaneix, CEO. He added, “With an estimated 35% of fusion cases producing adjacent disc disease, it is
clear that new, friendlier, motion preserving treatment options, that better replicate the natural movement
of the spine, are in the best interest of both the patient and society. The PERFX-2™ is a step in that
direction.”
"This Patent provides further validation of our innovative approach to spinal research and highlights the
potential for a significant advance in the treatment of a wide array of spinal indications,” added
Guillaume Viallaneix, CEO. “With this patent, along with the rest of our IP portfolio and our extensive
R&D efforts, we are in a strong position to move forward with our development plans in 2011 and
beyond.”
###
Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Eden Spine, LLC
Guillaume Viallaneix
407-792-2279
info@EdenSpine.com
www.EdenSpine.com
Online Version of Press Release:
You can read the online version of this press release at: http://www.pr.com/press-release/260764
News Image:
Page 2/2
PR.com Press Release Distribution Terms of Use